79 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

Page of 2 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AATKApoptosis-associated tyrosine kinaseEnzymes
Predicted membrane proteins
Tissue enhanced
ABL1C-abl oncogene 1, non-receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
ABL2C-abl oncogene 2, non-receptor tyrosine kinaseCancer-related genes
Enzymes
RAS pathway related proteins
Expressed in all
ALKAnaplastic lymphoma receptor tyrosine kinaseCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
AXLAXL receptor tyrosine kinaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Mixed
BLKB lymphoid tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Group enriched
BMXBMX non-receptor tyrosine kinaseEnzymes
Mixed
BTKBruton agammaglobulinemia tyrosine kinaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Tissue enhanced
CSF1RColony stimulating factor 1 receptorCancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
CSKC-src tyrosine kinaseEnzymes
Plasma proteins
Expressed in all
DDR1Discoidin domain receptor tyrosine kinase 1CD markers
Enzymes
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
EGFREpidermal growth factor receptorCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
EPHA1EPH receptor A1Cancer-related genes
Enzymes
Plasma proteins
Predicted membrane proteins
Tissue enhanced
EPHA10EPH receptor A10Enzymes
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
EPHA2EPH receptor A2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
EPHA3EPH receptor A3Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Mixed
EPHA4EPH receptor A4Cancer-related genes
Enzymes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Mixed
EPHA6EPH receptor A6Enzymes
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
EPHA7EPH receptor A7Cancer-related genes
Enzymes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Mixed
EPHA8EPH receptor A8Cancer-related genes
Enzymes
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
EPHB2EPH receptor B2Cancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Mixed
EPHB3EPH receptor B3Cancer-related genes
Enzymes
Predicted membrane proteins
Tissue enhanced
EPHB4EPH receptor B4Cancer-related genes
Enzymes
Plasma proteins
Predicted membrane proteins
Expressed in all
ERBB2V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
ERBB3V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3Cancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Mixed
ERBB4V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Group enriched
FERFer (fps/fes related) tyrosine kinaseEnzymes
Plasma proteins
Mixed
FESFeline sarcoma oncogeneCancer-related genes
Cytoskeleton related proteins
Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Expressed in all
FGFR1Fibroblast growth factor receptor 1Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
FGFR2Fibroblast growth factor receptor 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
FGFR3Fibroblast growth factor receptor 3Cancer-related genes
CD markers
Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
FGFR4Fibroblast growth factor receptor 4Cancer-related genes
CD markers
Enzymes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
FGRFeline Gardner-Rasheed sarcoma viral oncogene homologCytoskeleton related proteins
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Expressed in all
FLT1Fms-related tyrosine kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
FLT3Fms-related tyrosine kinase 3Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Mixed
FRKFyn-related kinaseEnzymes
FDA approved drug targets
Plasma proteins
Mixed
FYNFYN oncogene related to SRC, FGR, YESEnzymes
Plasma proteins
Expressed in all
HCKHemopoietic cell kinaseDisease related genes
Enzymes
Potential drug targets
Tissue enhanced
IGF1RInsulin-like growth factor 1 receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Expressed in all
INSRInsulin receptorCD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Expressed in all
INSRRInsulin receptor-related receptorEnzymes
Predicted membrane proteins
Tissue enhanced
JAK1Janus kinase 1Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
JAK2Janus kinase 2Cancer-related genes
Cytoskeleton related proteins
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
KDRKinase insert domain receptor (a type III receptor tyrosine kinase)Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
KITV-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homologCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
LCKLymphocyte-specific protein tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
LMTK2Lemur tyrosine kinase 2Enzymes
Predicted membrane proteins
Expressed in all
LMTK3Lemur tyrosine kinase 3Enzymes
Predicted membrane proteins
Tissue enriched
LTKLeukocyte receptor tyrosine kinaseDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Mixed
LYNV-yes-1 Yamaguchi sarcoma viral related oncogene homologCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Mixed

Page of 2 | next »